The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field

The clinical evaluation of convalescent plasma (CP) for the treatment of Ebola virus disease (EVD) in the current outbreak, predominantly affecting Guinea, Sierra Leone, and Liberia, was prioritized by the World Health Organization in September 2014. In each of these countries, nonrandomized compara...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Infect Dis
Autores principales: van Griensven, Johan, De Weiggheleire, Anja, Delamou, Alexandre, Smith, Peter G., Edwards, Tansy, Vandekerckhove, Philippe, Bah, Elhadj Ibrahima, Colebunders, Robert, Herve, Isola, Lazaygues, Catherine, Haba, Nyankoye, Lynen, Lutgarde
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2016
Materias:
Viewpoints
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4678103/
https://ncbi.nlm.nih.gov/pubmed/26261205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ680
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares